Does USTEKINUMAB Cause Bursitis? 1,082 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,082 reports of Bursitis have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 1.3% of all adverse event reports for USTEKINUMAB.
1,082
Reports of Bursitis with USTEKINUMAB
1.3%
of all USTEKINUMAB reports
878
Deaths
982
Hospitalizations
How Dangerous Is Bursitis From USTEKINUMAB?
Of the 1,082 reports, 878 (81.1%) resulted in death, 982 (90.8%) required hospitalization, and 984 (90.9%) were considered life-threatening.
Is Bursitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 1,082 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Bursitis?
ADALIMUMAB (2,448)
TOCILIZUMAB (2,094)
RITUXIMAB (2,075)
METHOTREXATE (2,060)
ABATACEPT (1,903)
ALENDRONATE (1,873)
ETANERCEPT (1,768)
SECUKINUMAB (1,755)
LEFLUNOMIDE (1,728)
CETIRIZINE (1,706)
Which USTEKINUMAB Alternatives Have Lower Bursitis Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE